Imperative Care office

About
Imperative Care

Who We Are

With patients as our North Star, we develop innovations that deliver a real impact for patients and their families, with a focus on making these technologies available more broadly.


With three commercially available product portfolios that address specific gaps in treatment and care of stroke and vascular disease, and more programs underway, Imperative Care is committed to rapid innovation across the entire patient journey. 

Body chart with labels

Innovating Across the Entire Patient Experience

Our vision is grander than a singular technology solution. By bringing together dedicated product portfolios – each focused on addressing a specific gap in the care continuum – under one collective vision, we are better positioned to expand and improve patient care.

Driven By Urgency

When a blood clot blocks a vital vessel, time is of the essence. Whether it’s within minutes, hours or days, the patient will suffer life-changing damage if the clot isn’t removed quickly. That’s why we’re engineering solutions to give patients the best chance at a full recovery and restored independence.

1 https://www.cdc.gov/stroke/data-research/facts-stats/index.html

2 https://www.emro.who.int/health-topics/stroke-cerebrovascular-accident/index.html

A Future Built on Innovation

We know that the future is dependent on the innovations we invest in today.

Our Core Tenents

Without compromising quality, we move swiftly through our development cycle, with an emphasis on testing, clinical evidence, and physician feedback. This strategic agility enables us to react quickly to the needs of physicians and their patients.

Our physician-driven approach to innovation puts the needs, perspectives and ideas of front-line doctors at the center of our research and development process.

From our large, prospective, multicenter Imperative Trial and pivotal SYMPHONY-PE Study to smaller, single-center studies, we are committed to validating our technologies and solutions with robust clinical data.